ISOXAZOLINE COMPOSITIONS AND THEIR USE AS ANTIPARASITICS
    7.
    发明申请
    ISOXAZOLINE COMPOSITIONS AND THEIR USE AS ANTIPARASITICS 审中-公开
    ISOXAZOLINE组合物及其作为抗菌剂的用途

    公开(公告)号:US20160332975A1

    公开(公告)日:2016-11-17

    申请号:US15222171

    申请日:2016-07-28

    申请人: Intervet Inc.

    摘要: This invention relates to methods for controlling parasitic infestations of animals and their environments, and, more particularly, to methods using isoxazolines to control parasites in or on animals or in their environments, as well as treat parasitoses of animals. The isoxazolines include 4-(isoxazolinyl)-benzamides (specifically, substituted 4-(5-(halomethyl)-5-phenyl-isoxazolin-3-yl)-benzamides) and 4-(isoxazolinyl)-benzothioamides (specifically, substituted 4-(5-(halomethyl)-5-phenyl-isoxazolin-3-yl)-benzothioamides). This invention also relates to compositions comprising the isoxazolines for use in such methods, the use of the isoxazolines to make medicaments for use in such methods, and kits comprising the isoxazolines for carrying out such methods. This invention further relates to the use of the isoxazolines as medicaments, particularly medicaments that can be used in the above-referenced method.

    摘要翻译: 本发明涉及用于控制动物及其环境的寄生虫感染的方法,更具体地,涉及使用异恶唑啉来控制动物或其环境中或动物或其环境中的寄生虫以及治疗动物寄生虫的方法。 异恶唑啉包括4-(异恶唑啉基) - 苯甲酰胺(具体地,取代的4-(5-(卤代甲基)-5-苯基 - 异恶唑啉-3-基) - 苯甲酰胺)和4-(异恶唑啉基) - 苯并硫代酰胺(具体地, (5-(卤代甲基)-5-苯基 - 异恶唑啉-3-基) - 苯并硫代酰胺)。 本发明还涉及包含用于此类方法的异恶唑烷的组合物,异恶唑啉用于制备用于此类方法的药物的用途,以及包含用于进行此类方法的异恶唑啉的试剂盒。 本发明还涉及异恶唑啉作为药物的用途,特别是可以在上述方法中使用的药物。

    ISOXAZOLINE COMPOSITIONS AND THEIR USE AS ANTIPARASITICS

    公开(公告)号:US20210061775A1

    公开(公告)日:2021-03-04

    申请号:US17021698

    申请日:2020-09-15

    申请人: Intervet Inc.

    摘要: This invention relates to methods for controlling parasitic infestations of animals and their environments, and, more particularly, to methods using isoxazolines to control parasites in or on animals or in their environments, as well as treat parasitoses of animals. The isoxazolines include 4-(isoxazolinyl)-benzamides (specifically, substituted 4-(5-(halomethyl)-5-phenyl-isoxazolin-3-yl)-benzamides) and 4-(isoxazolinyl)-benzothioamides (specifically, substituted 4-(5-(halomethyl)-5-phenyl-isoxazolin-3-yl)-benzothioamides). This invention also relates to compositions comprising the isoxazolines for use in such methods, the use of the isoxazolines to make medicaments for use in such methods, and kits comprising the isoxazolines for carrying out such methods. This invention further relates to the use of the isoxazolines as medicaments, particularly medicaments that can be used in the above-referenced method.